{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T15:02:44.254059+00:00","company":{"ticker":"LLY","cik":59478,"company_name":"ELI LILLY & Co"},"pagination":{"limit":100,"returned":18,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"0020f2abd9eb9dc86d5f0fad1a4d64ca38835419","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2026-04-30T23:59:59+00:00","payload":{"eps_text":"35.50 to 37.00","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"FY 2026","report_date":"2026-04-30","result_type":"guidance_update","revenue_text":"82.0 billion to 85.0 billion"},"claim":"ELI LILLY & Co reported FY 2026 results: revenue 82.0 billion to 85.0 billion, EPS 35.50 to 37.00. Guidance raised.","evidence_excerpt":"Increased 2026 full-year revenue guidance to be in the range of $82.0 billion to $85.0 billion and non-GAAP EPS guidance to be in the range of $35.50 to $37.00.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000059478-26-000043","anchor_url":"https://secwatch.observer/filing/0000059478-26-000043#claim-0020f2abd9eb9dc86d5f0fad1a4d64ca38835419","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947826000043/0000059478-26-000043-index.htm"},{"fact_type":"earnings_release","fact_key":"f1508fcbb9e0fe43c2b66e19d456c99c15363b06","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2026-04-30T23:59:59+00:00","payload":{"eps_text":"8.26","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"7,396","period_text":"Q1 2026","report_date":"2026-04-30","result_type":"reported_results","revenue_text":"19,799"},"claim":"ELI LILLY & Co reported Q1 2026 results: revenue 19,799, net income 7,396, EPS 8.26.","evidence_excerpt":"Revenue $ 19,799 $ 12,729 56% Net income – Reported 7,396 2,759 168% Earnings per share – Reported 8.26 3.06 170%","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000059478-26-000043","anchor_url":"https://secwatch.observer/filing/0000059478-26-000043#claim-f1508fcbb9e0fe43c2b66e19d456c99c15363b06","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947826000043/0000059478-26-000043-index.htm"},{"fact_type":"executive_change","fact_key":"c8ad6f6118","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-11-19T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-12-31","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Karen Walker resigned as Director at ELI LILLY & Co.","evidence_excerpt":"Karen Walker notified the Board of her resignation from the Board effective December 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000258","anchor_url":"https://secwatch.observer/filing/0000059478-24-000258#claim-c8ad6f6118","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000258/0000059478-24-000258-index.htm"},{"fact_type":"executive_change","fact_key":"7d993571a8","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-09-09T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-09-09","interim":false,"role":"executive vice president and chief financial officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Lucas Montarce was elected as executive vice president and chief financial officer at ELI LILLY & Co.","evidence_excerpt":"elected Lucas Montarce, age 47, as executive vice president and chief financial officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000213","anchor_url":"https://secwatch.observer/filing/0000059478-24-000213#claim-7d993571a8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000213/0000059478-24-000213-index.htm"},{"fact_type":"executive_change","fact_key":"dd0a97d112","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-08-16T23:59:59+00:00","payload":{"action":"retired","action_category":"departure","departure_tone":"retirement","effective_date":"2024-08-31","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Marschall S. Runge retired as Director at ELI LILLY & Co.","evidence_excerpt":"On August 13, 2024, Dr. Marschall S. Runge notified the Board of Directors (the \"Board\") of Eli Lilly and Company (the \"Company\") of his decision to retire from the Board, effective as of August 31, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000196","anchor_url":"https://secwatch.observer/filing/0000059478-24-000196#claim-dd0a97d112","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000196/0000059478-24-000196-index.htm"},{"fact_type":"executive_change","fact_key":"2115202a52","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-07-10T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-15","interim":true,"role":"interim chief financial officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Gordon Brooks was appointed as interim chief financial officer at ELI LILLY & Co.","evidence_excerpt":"Effective July 15, 2024, Gordon Brooks, age 55, group vice president, controller and corporate strategy, of the Company, will assume the role of interim chief financial officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000164","anchor_url":"https://secwatch.observer/filing/0000059478-24-000164#claim-2115202a52","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164-index.htm"},{"fact_type":"executive_change","fact_key":"558d0375bb","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-07-10T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"executive vice president and chief financial officer","role_category":"cfo","successor_name":"Gordon Brooks","successor_named":true},"claim":"Anat Ashkenazi resigned as executive vice president and chief financial officer at ELI LILLY & Co.","evidence_excerpt":"On June 5, 2024, Eli Lilly and Company (the “Company”) announced that Anat Ashkenazi resigned as executive vice president and chief financial officer of the Company to pursue another career opportunity outside of the pharmaceutical industry.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000164","anchor_url":"https://secwatch.observer/filing/0000059478-24-000164#claim-558d0375bb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164-index.htm"},{"fact_type":"executive_change","fact_key":"fe3c0ae7f0","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-06-05T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Anat Ashkenazi resigned as Executive Vice President and Chief Financial Officer at ELI LILLY & Co.","evidence_excerpt":"Anat Ashkenazi resigned as Executive Vice President and Chief Financial Officer of the Company to pursue another career opportunity outside of the pharmaceutical industry.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000146","anchor_url":"https://secwatch.observer/filing/0000059478-24-000146#claim-fe3c0ae7f0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000146/0000059478-24-000146-index.htm"},{"fact_type":"shareholder_vote","fact_key":"86c23dc52033f6153567f5b204309548445a633f","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"failed","proposal_text":"Shareholder proposal for Company to adopt a comprehensive human rights policy","proposal_type":"other","votes_abstain_text":"5,698,325","votes_against_text":"691,658,094","votes_for_text":"77,058,700"},"claim":"ELI LILLY & Co shareholders rejected Shareholder proposal for Company to adopt a comprehensive human rights policy at the 2024-05-06 meeting.","evidence_excerpt":"By the following vote, a shareholder proposal for the Company to adopt a comprehensive human rights policy was not approved: For Against Abstain Broker Nonvote 77,058,700 691,658,094 5,698,325 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-86c23dc52033f6153567f5b204309548445a633f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"f17aa2a61c175124524d19640936aa22fa6da574","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"failed","proposal_text":"Shareholder proposal requesting to establish and report on a process by which impact of extended patent exclusivities on product access would be considered","proposal_type":"other","votes_abstain_text":"6,506,288","votes_against_text":"699,538,270","votes_for_text":"68,370,561"},"claim":"ELI LILLY & Co shareholders rejected Shareholder proposal requesting to establish and report on a process by which impact of extended patent exclusivities on product access would be considered at the 2024-05-06 meeting.","evidence_excerpt":"By the following vote, a shareholder proposal requesting to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents was not approved: For Against Abstain Broker Nonvote 68,370,561 699,538,270 6,506,288 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-f17aa2a61c175124524d19640936aa22fa6da574","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"7533e3319bf33e4c715612cdc5f9c6fff234d293","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"failed","proposal_text":"Shareholder proposal requesting report on effectiveness of diversity, equity, and inclusion efforts","proposal_type":"other","votes_abstain_text":"4,399,601","votes_against_text":"586,886,679","votes_for_text":"183,128,839"},"claim":"ELI LILLY & Co shareholders rejected Shareholder proposal requesting report on effectiveness of diversity, equity, and inclusion efforts at the 2024-05-06 meeting.","evidence_excerpt":"By the following vote, a shareholder proposal requesting a report on the effectiveness of the Company's diversity, equity, and inclusion efforts was not approved: For Against Abstain Broker Nonvote 183,128,839 586,886,679 4,399,601 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-7533e3319bf33e4c715612cdc5f9c6fff234d293","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"bf4471d828bd4c998114cd406eae9d8c3b5d29b6","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"failed","proposal_text":"Shareholder proposal requesting publication of annual report disclosing lobbying activities","proposal_type":"other","votes_abstain_text":"12,848,463","votes_against_text":"567,382,406","votes_for_text":"194,184,250"},"claim":"ELI LILLY & Co shareholders rejected Shareholder proposal requesting publication of annual report disclosing lobbying activities at the 2024-05-06 meeting.","evidence_excerpt":"By the following vote, a shareholder proposal requesting publication of an annual report disclosing lobbying activities was not approved: For Against Abstain Broker Nonvote 194,184,250 567,382,406 12,848,463 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-bf4471d828bd4c998114cd406eae9d8c3b5d29b6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"28d52cb136f7449acab8c29f820725dccf101c05","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"failed","proposal_text":"Amend Articles of Incorporation to eliminate supermajority voting provisions","proposal_type":"charter_amendment","votes_abstain_text":"1,118,963","votes_against_text":"108,058,286","votes_for_text":"665,237,870"},"claim":"ELI LILLY & Co shareholders rejected Amend Articles of Incorporation to eliminate supermajority voting provisions at the 2024-05-06 meeting.","evidence_excerpt":"The proposal to amend the Articles to eliminate supermajority voting provisions did not receive the required vote of 80% of outstanding shares. The shareholders voted as follows: For Against Abstain Broker Nonvote 665,237,870 108,058,286 1,118,963 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-28d52cb136f7449acab8c29f820725dccf101c05","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"0fbecf1bdec4d6d40b2eeebcc08b4fc393bfe60e","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"failed","proposal_text":"Amend Articles of Incorporation to eliminate classified board structure","proposal_type":"charter_amendment","votes_abstain_text":"1,439,284","votes_against_text":"106,518,999","votes_for_text":"666,456,836"},"claim":"ELI LILLY & Co shareholders rejected Amend Articles of Incorporation to eliminate classified board structure at the 2024-05-06 meeting.","evidence_excerpt":"The proposal to amend the Company's Articles of Incorporation (the “Articles”) to eliminate the classified board structure did not receive the required vote of 80% of outstanding shares. The shareholders voted as follows: For Against Abstain Broker Nonvote 666,456,836 106,518,999 1,439,284 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-0fbecf1bdec4d6d40b2eeebcc08b4fc393bfe60e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"4125689ccdde8ade3f0600b8fffd365d10226bc8","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"passed","proposal_text":"Ratification of Ernst & Young LLP as independent auditor for 2024","proposal_type":"auditor_ratification","votes_abstain_text":"1,100,650","votes_against_text":"35,914,315","votes_for_text":"819,656,263"},"claim":"ELI LILLY & Co shareholders approved Ratification of Ernst & Young LLP as independent auditor for 2024 at the 2024-05-06 meeting.","evidence_excerpt":"The appointment of Ernst & Young LLP as the Company's independent auditor for 2024 was ratified by the following shareholder vote: For Against Abstain 819,656,263 35,914,315 1,100,650","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-4125689ccdde8ade3f0600b8fffd365d10226bc8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"9a7c50fc857080ec31a3a734ccb3296dd7d7b346","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"passed","proposal_text":"Advisory approval of compensation paid to named executive officers","proposal_type":"say_on_pay","votes_abstain_text":"1,815,408","votes_against_text":"38,576,757","votes_for_text":"734,022,954"},"claim":"ELI LILLY & Co shareholders approved Advisory approval of compensation paid to named executive officers at the 2024-05-06 meeting.","evidence_excerpt":"By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers: For Against Abstain Broker Nonvote 734,022,954 38,576,757 1,815,408 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-9a7c50fc857080ec31a3a734ccb3296dd7d7b346","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"shareholder_vote","fact_key":"8e04a3dc09561f4208474eea1615087cfcc5ad53","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-05-09T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2024-05-06","outcome":"passed","proposal_text":"Election of four nominees for director to serve three-year terms ending in 2027","proposal_type":"director_election","votes_abstain_text":"874,425; 903,495; 999,185; 993,364","votes_against_text":"4,790,679; 66,489,475; 16,842,872; 14,553,438","votes_for_text":"768,750,015; 707,022,149; 756,573,062; 758,868,317"},"claim":"ELI LILLY & Co shareholders approved Election of four nominees for director to serve three-year terms ending in 2027 at the 2024-05-06 meeting.","evidence_excerpt":"The four nominees for director were elected to serve three-year terms ending at the Company's annual meeting of shareholders in 2027, as follows: Nominee For Against Abstain Broker Nonvote Katherine Baicker, Ph.D. 768,750,015 4,790,679 874,425 82,256,109 J. Erik Fyrwald 707,022,149 66,489,475 903,495 82,256,109 Jamere Jackson 756,573,062 16,842,872 999,185 82,256,109 Gabrielle Sulzberger 758,868,317 14,553,438 993,364 82,256,109","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000127","anchor_url":"https://secwatch.observer/filing/0000059478-24-000127#claim-8e04a3dc09561f4208474eea1615087cfcc5ad53","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm"},{"fact_type":"earnings_release","fact_key":"07856b6cd4f97bf689c18ac29b3b3ede725165c3","cik":59478,"ticker":"LLY","company_name":"ELI LILLY & Co","filed_at":"2024-04-30T23:59:59+00:00","payload":{"eps_text":"$2.48","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$2,242.9","period_text":"first quarter of 2024","report_date":"2024-04-30","result_type":"reported_results","revenue_text":"$8,768.0"},"claim":"ELI LILLY & Co reported first quarter of 2024 results: revenue $8,768.0, net income $2,242.9, EPS $2.48. Guidance raised.","evidence_excerpt":"on important public announcements, visit the news section of Lilly's website. Financial Results $ in millions, except per share data First Quarter 2024 2023 % Change Revenue $ 8,768.0 $ 6,960.0 26% Net income – Reported 2,242.9 1,344.9 67% Earnings per share – Reported 2.48 1.49 66% Net income – Non-GAAP 2,335.3 1,463.9 60% Earnings per share – Non-GAAP 2.58","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000059478-24-000116","anchor_url":"https://secwatch.observer/filing/0000059478-24-000116#claim-07856b6cd4f97bf689c18ac29b3b3ede725165c3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/59478/000005947824000116/0000059478-24-000116-index.htm"}]}